5-Aminosalicylates and renal function in
β
Javier P. Gisbert; Yago GonzΓ‘lez-Lama; JosΓ© MatΓ©
π
Article
π
2007
π
John Wiley and Sons
π
English
β 114 KB
π 2 views
Nephrotoxicity has been described in some patients with inflammatory bowel disease (IBD) treated with 5-aminosalicylic acid (5-ASA). Studies with 5-ASA treatment in which serum creatinine or creatinine clearance was measured regularly show that nephrotoxicity is exceptional (mean rate of only 0.26%